Almost all these drugs are "ME TOO" drugs, copies of something already on the market and have little chance of being a big earner.
The antibiotic by ADLS, I'm not familiar with, but assume it's a ME TOO also.
One of the cancer drugs has so many restrictions that only a few hundred people a year would take it even if it's approved.
That leaves one cancer drug that might, might, be a winner, but cancer drugs have a history of disappointing, so a roll at the craps table would probably be a more likely winner.
13 Extreme FDA Trades [View article]
copies of something already on the market and have little chance of being a big earner.
The antibiotic by ADLS, I'm not familiar with, but assume it's a ME TOO also.
One of the cancer drugs has so many restrictions that only a few hundred people a year would take it even if it's approved.
That leaves one cancer drug that might, might, be a winner,
but cancer drugs have a history of disappointing,
so a roll at the craps table would probably be a more likely winner.